OCD Trial, Recruiting (NCT06934525)

OCD Trial, Recruiting NCT06934525 Sponsor: Bradley Hospital Condition: OCD

Printed from Voxsanity (voxsanity.com.au) — NCT06934525 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ocd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The patient must be between 5 and 18 years old (inclusive)
The patient must have a main or shared main diagnosis of anxiety or OCD according to standard diagnostic guidelines (DSM-V)
Symptoms must have been present for at least 3 months
The patient must need outpatient care (treatment without staying overnight in a hospital)
There must be a stable parent or guardian who is able to take part in the treatment alongside the patient

Who may not be able to join:

The patient has another main mental health condition that currently needs its own active treatment
The patient is experiencing acute suicidal thoughts or urges at this time
The patient is already receiving another form of talking therapy or psychological treatment at the same time
The patient has a long-term physical health condition that would prevent them from fully taking part in the treatment
The patient is taking psychiatric medication that has not yet reached a stable, consistent dose (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 401-432-1000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06934525

Sponsor: Bradley Hospital

Phase: Not Applicable

Status: Recruiting

Condition: OCD

Trial contact: 401-432-1000

More information: https://clinicaltrials.gov/study/NCT06934525

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The patient must be between 5 and 18 years old (inclusive)
The patient must have a main or shared main diagnosis of anxiety or OCD according to standard diagnostic guidelines (DSM-V)
Symptoms must have been present for at least 3 months
The patient must need outpatient care (treatment without staying overnight in a hospital)
There must be a stable parent or guardian who is able to take part in the treatment alongside the patient

Who may not be able to join:

The patient has another main mental health condition that currently needs its own active treatment
The patient is experiencing acute suicidal thoughts or urges at this time
The patient is already receiving another form of talking therapy or psychological treatment at the same time
The patient has a long-term physical health condition that would prevent them from fully taking part in the treatment
The patient is taking psychiatric medication that has not yet reached a stable, consistent dose (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Bradley Hospital

Registry

ClinicalTrials.gov

Start date

1 November 2025

Est. completion

1 February 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Children's Yale-Brown Obsessive-Compulsive Scale Second Edition: (CY-BOCS II); Client Satisfaction Questionnaire-Revised (CSQ-8-R); Exposure Guide; Pediatric Anxiety Rating Scale (PARS); Clinical Global Impression Scales; Top Problems Assessment; Child Sheehan Disability Scale (CSDS); Barriers to Treatment Questionnaire - Parent Version (BTQ-P)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov